Skip to main content
Journal of Hematology & Oncology logoLink to Journal of Hematology & Oncology
. 2021 Feb 17;14:31. doi: 10.1186/s13045-021-01043-z

Correction to: MCL-1 inhibitors, fast-lane development of a new class of anti-cancer agents

Arnold Bolomsky 1, Meike Vogler 2, Murat Cem Köse 3, Caroline A Heckman 4, Grégory Ehx 3, Heinz Ludwig 1, Jo Caers 3,
PMCID: PMC7888147  PMID: 33596924

Correction to: J Hematol Oncol (2020) 13:173 10.1186/s13045-020-01007-9

The original article contains an incorrect affiliation for co-author, Meike Vogler. The correct affiliation can be viewed in this Correction article.

Footnotes

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Reference

  • 1.Bolomsky A, et al. MCL-1 inhibitors, fast-lane development of a new class of anti-cancer agents. J Hematol Oncol. 2020;13:173. doi: 10.1186/s13045-020-01007-9. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Hematology & Oncology are provided here courtesy of BMC

RESOURCES